A PROSPECTIVE RANDOMIZED TRIAL OF 5-FLUOROURACIL VERSUS 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN VERSUS 5-FLUOROURACIL AND METHOTREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA

被引：456
|
作者：
PETRELLI, N
HERRERA, L
RUSTUM, Y
BURKE, P
CREAVEN, P
STULC, J
EMRICH, LJ
MITTELMAN, A
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT THERAPEUT,BUFFALO,NY 14263
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263
[4] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT BIOMATH,BUFFALO,NY 14263
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 10期
关键词：
D O I：
10.1200/JCO.1987.5.10.1559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1559 / 1565
页数：7
相关论文
共 50 条
  • [41] Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma
    Cocconi, G
    Carlini, P
    Garnboni, A
    Gasperoni, S
    Rodinò, C
    Zironi, S
    Bisagni, G
    Porrozzi, S
    Cognetti, F
    Di Costanzo, F
    Canaletti, R
    Ruggeri, EM
    Carnisa, R
    Pucci, F
    ANNALS OF ONCOLOGY, 2003, 14 (08) : 1258 - 1263
  • [42] A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer - A Hellenic Cooperative Oncology Group (HeCOG) study
    Kalofonos, HP
    Nicolaides, C
    Samantas, E
    Mylonakis, N
    Aravantinos, G
    Dimopoulos, MA
    Gennatas, C
    Kouvatseas, G
    Giannoulis, E
    Dervenis, C
    Basdanis, G
    Pavlidis, N
    Androulakis, I
    Fountzilas, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (01): : 23 - 30
  • [43] Double modulation of 5-fluorouracil by trimetrexate and leucovorin in patients with advanced colorectal carcinoma
    Machiavelli, MR
    Salum, G
    Pérez, JE
    Ortiz, EH
    Romero, AO
    Bologna, F
    Vallejo, CT
    Lacava, JA
    Dominguez, ME
    Leone, BA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (02): : 149 - 154
  • [44] RANDOMIZED COMPARISON OF WEEKLY BOLUS 5-FLUOROURACIL WITH OR WITHOUT LEUCOVORIN IN METASTATIC COLORECTAL-CARCINOMA
    NOBILE, MT
    ROSSO, R
    SERTOLI, MR
    RUBAGOTTI, A
    VIDILI, MG
    GUGLIELMI, A
    VENTURINI, M
    CANOBBIO, L
    FASSIO, T
    GALLO, L
    GALLIGIONI, E
    GALLOTTI, P
    BRUZZI, P
    SOBRERO, A
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (11) : 1823 - 1827
  • [45] 5-fluorouracil alone versus 5-fluorouracil plus folinic acid in the treatment of colorectal carcinoma: meta-analysis
    Lo Bello, L
    Pistone, G
    Restuccia, S
    Vinci, E
    Mazzoleni, G
    Malaguarnera, M
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2000, 38 (12) : 553 - 562
  • [46] SEQUENTIAL HIGH-DOSE METHOTREXATE AND 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    HEIM, ME
    FLECHTNER, H
    EDLER, L
    QUEISSER, W
    TUMORDIAGNOSTIK & THERAPIE, 1986, 7 (05) : 197 - 200
  • [47] Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
    André, T
    Louvet, C
    Raymond, E
    Tournigand, C
    de Gramont, A
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1251 - 1253
  • [48] 5-FLUOROURACIL PLUS HIGH-DOSE LEUCOVORIN FOR THERAPY OF 5-FLUOROURACIL-RESISTANT METASTATIC COLORECTAL-CANCER
    OSTERWALDER, B
    SCHMID, L
    JUNGI, WF
    SENN, HJ
    BLUT, 1988, 57 (04): : 207 - 207
  • [49] A PHASE-III RANDOMIZED STUDY OF 5-FLUOROURACIL AND CISPLATIN VERSUS 5-FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN-C VERSUS 5-FLUOROURACIL ALONE IN THE TREATMENT OF ADVANCED GASTRIC-CANCER
    KIM, NK
    PARK, YS
    HEO, DS
    SUH, C
    KIM, SY
    PARK, KC
    KANG, YK
    SHIN, DB
    KIM, HT
    KIM, HJ
    KANG, WK
    SUH, CI
    BANG, YJ
    CANCER, 1993, 71 (12) : 3813 - 3818
  • [50] Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer
    Huguier, M
    Barrier, A
    Valinas, R
    Flahault, A
    Adloff, M
    Pezet, D
    Jaeck, D
    Millat, B
    HEPATO-GASTROENTEROLOGY, 2001, 48 (39) : 875 - 878
12345